Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Resource Type
Article
Authors
Pigeon-Kherchiche, Patricia ; Flaus-Furmaniuk, Anna ; Bald, Martin ; Denzer, Christian ; von Schnurbein, Julia ; Abawi, Ozair ; Blume-Peytavi, Ulrike ; Krabusch, Philipp ; Mai, Knut ; Schnabel, Dirk ; Wiegand, Susanna ; Flück, Christa E ; Schulz, Esther ; Voss, Egbert ; Bratina, Natasa ; Weiss, Katja ; Martos-Moreno, Gabriel Á ; Danset, Alban ; Gougis, Paul ; Dubern, Béatrice ; Clément, Karine ; van den Akker, Erica L.T. ; Argente, Jesús ; Bahm, Allison L ; Chung, Wendy K ; Connors, Hillori S ; De Waele, Kathleen ; Farooqi, Ismaa Sadaf ; Gonneau-Lejeune, Julie ; Gordon, Gregory A ; Poitou, Christine ; Puder, Lia ; Swain, James M ; Stewart, Murray W ; Yuan, Goujun ; Wabitsch, Martin ; Kühnen, Peter ; van den Akker, Erica ; Bahm, Allison ; Connors, Hillori ; Farooqi, I Sadaf ; Gordon, Gregory ; Kohlsdorf, Katja ; Swain, James ; Stewart, Murray ; Yuan, Guojun
Source
In The Lancet Diabetes & Endocrinology December 2020 8(12):960-970
Subject
Primary Research Articles
Language
ISSN
2213-8587